FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1565332331> ?p ?o ?g. }

• W1565332331 endingPage "160" @default.
• W1565332331 startingPage "160" @default.
• W1565332331 abstract "Objective National medicines policies (NMP) provide a means for governments to achieve their objectives in relation to pharmaceuticals and other medicines. This research aimed to identify challenges to implementing the objectives of the Australian NMP from the perspective of key stakeholders. Methods In 2012 and 2103, we conducted 30 semistructured interviews with stakeholders involved in the discovery, clinical testing, regulation and funding of medicines in Australia. We asked participants to describe their careers and to give their opinions on specific issues surrounding drug development, clinical research, regulation and subsidisation in Australia. Data were analysed using Morse’s outline of the cognitive basis of qualitative research and Charmaz’s outline of data analysis in grounded theory. The initial phase of ‘open coding’ revealed findings that could be mapped to three of the four objectives of the NMP. We then conducted ‘focussed coding’ for themes relevant to these objectives. Results Participants identified many issues relevant to the ongoing evolution of the NMP, relating primarily to ongoing tensions between the commercial objective of ensuring a viable medicines industry, and the non-commercial objectives of ensuring that medicines are safe, effective and affordable. There were also several other challenges identified to the achievement of both the commercial and non-commercial objectives of the NMP. These included limits to government funding, globalisation, consumer advocacy, changing scientific paradigms and new information technologies. Conclusions There are many issues that need to be addressed if policymakers are to achieve the best outcomes from the NMP. Tensions between the commercial and non-commercial objectives of the NMP suggest the need to ensure that one stakeholder group’s imperatives do not stifle those of other groups. At the same time, there are several emerging issues that are likely to concern all stakeholders equally, and these are both challenges and opportunities for new kinds of collaboration. What is known about the topic? We know that stakeholders have several concerns about medicines policy, but little is known about the specific challenges to implementing medicines policy from the perspective of those involved. What does this paper add? We demonstrate that stakeholders have many concerns that could impact the implementation of medicines policies. These relate primarily to ongoing tensions between the objective of ensuring a viable medicines industry, and the objectives of ensuring that medicines are safe, effective and affordable. There are also several issues that potentially pose a challenge to achieving both the commercial and non-commercial objectives of the NMP. These include limits to government funding, globalisation, consumer advocacy, changing scientific paradigms and new information technologies. What are the implications for practitioners? Policymakers need to systematically address the barriers to the ongoing implementation of the NMP. Policymakers should also ensure that one imperative (such as the commercial imperative) does not stifle other objectives. Other emerging issues are likely to concern all stakeholders, and these provide opportunities for new kinds of collaboration among stakeholders." @default.
• W1565332331 created "2016-06-24" @default.
• W1565332331 creator A5036753243 @default.
• W1565332331 creator A5047202475 @default.
• W1565332331 creator A5051780864 @default.
• W1565332331 creator A5067007569 @default.
• W1565332331 date "2014-01-01" @default.
• W1565332331 modified "2023-09-27" @default.
• W1565332331 title "Challenges to pharmaceutical policymaking: lessons from Australia’s national medicines policy" @default.
• W1565332331 cites W1965958981 @default.
• W1565332331 cites W2045979321 @default.
• W1565332331 cites W2080814922 @default.
• W1565332331 cites W2098786187 @default.
• W1565332331 cites W2138301676 @default.
• W1565332331 cites W2149410143 @default.
• W1565332331 cites W2170425777 @default.
• W1565332331 cites W2333028392 @default.
• W1565332331 cites W2416682008 @default.
• W1565332331 doi "https://doi.org/10.1071/ah13240" @default.
• W1565332331 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24589424" @default.
• W1565332331 hasPublicationYear "2014" @default.
• W1565332331 type Work @default.
• W1565332331 sameAs 1565332331 @default.
• W1565332331 citedByCount "2" @default.
• W1565332331 countsByYear W15653323312017 @default.
• W1565332331 countsByYear W15653323312021 @default.
• W1565332331 crossrefType "journal-article" @default.
• W1565332331 hasAuthorship W1565332331A5036753243 @default.
• W1565332331 hasAuthorship W1565332331A5047202475 @default.
• W1565332331 hasAuthorship W1565332331A5051780864 @default.
• W1565332331 hasAuthorship W1565332331A5067007569 @default.
• W1565332331 hasBestOaLocation W15653323312 @default.
• W1565332331 hasConcept C118552586 @default.
• W1565332331 hasConcept C138816342 @default.
• W1565332331 hasConcept C138885662 @default.
• W1565332331 hasConcept C144024400 @default.
• W1565332331 hasConcept C144133560 @default.
• W1565332331 hasConcept C156325361 @default.
• W1565332331 hasConcept C159110408 @default.
• W1565332331 hasConcept C17744445 @default.
• W1565332331 hasConcept C190248442 @default.
• W1565332331 hasConcept C22607594 @default.
• W1565332331 hasConcept C2778137410 @default.
• W1565332331 hasConcept C2778149918 @default.
• W1565332331 hasConcept C36289849 @default.
• W1565332331 hasConcept C39549134 @default.
• W1565332331 hasConcept C41895202 @default.
• W1565332331 hasConcept C524218345 @default.
• W1565332331 hasConcept C71924100 @default.
• W1565332331 hasConceptScore W1565332331C118552586 @default.
• W1565332331 hasConceptScore W1565332331C138816342 @default.
• W1565332331 hasConceptScore W1565332331C138885662 @default.
• W1565332331 hasConceptScore W1565332331C144024400 @default.
• W1565332331 hasConceptScore W1565332331C144133560 @default.
• W1565332331 hasConceptScore W1565332331C156325361 @default.
• W1565332331 hasConceptScore W1565332331C159110408 @default.
• W1565332331 hasConceptScore W1565332331C17744445 @default.
• W1565332331 hasConceptScore W1565332331C190248442 @default.
• W1565332331 hasConceptScore W1565332331C22607594 @default.
• W1565332331 hasConceptScore W1565332331C2778137410 @default.
• W1565332331 hasConceptScore W1565332331C2778149918 @default.
• W1565332331 hasConceptScore W1565332331C36289849 @default.
• W1565332331 hasConceptScore W1565332331C39549134 @default.
• W1565332331 hasConceptScore W1565332331C41895202 @default.
• W1565332331 hasConceptScore W1565332331C524218345 @default.
• W1565332331 hasConceptScore W1565332331C71924100 @default.
• W1565332331 hasIssue "2" @default.
• W1565332331 hasLocation W15653323311 @default.
• W1565332331 hasLocation W15653323312 @default.
• W1565332331 hasLocation W15653323313 @default.
• W1565332331 hasOpenAccess W1565332331 @default.
• W1565332331 hasPrimaryLocation W15653323311 @default.
• W1565332331 hasRelatedWork W1563743605 @default.
• W1565332331 hasRelatedWork W1982750067 @default.
• W1565332331 hasRelatedWork W2052175617 @default.
• W1565332331 hasRelatedWork W2076885379 @default.
• W1565332331 hasRelatedWork W2112431673 @default.
• W1565332331 hasRelatedWork W2127155492 @default.
• W1565332331 hasRelatedWork W2417290802 @default.
• W1565332331 hasRelatedWork W2510020263 @default.
• W1565332331 hasRelatedWork W2977498308 @default.
• W1565332331 hasRelatedWork W4232087584 @default.
• W1565332331 hasVolume "38" @default.
• W1565332331 isParatext "false" @default.
• W1565332331 isRetracted "false" @default.
• W1565332331 magId "1565332331" @default.
• W1565332331 workType "article" @default.